Tracer selection with different stress modalities based on tracer kinetics.
Heller
G V
GV
University of Connecticut School of Medicine, Hartford Hospital 06102, USA.
D003326:Coronary Circulation; D003327:Coronary Disease / Q000000981:diagnostic imaging*; D003331:Coronary Vessels / Q000378:metabolism; D005080:Exercise Test; D005663:Furans / Q000493:pharmacokinetics; D006801:Humans; D009206:Myocardium / Q000378:metabolism; D009943:Organophosphorus Compounds / Q000493:pharmacokinetics; D015609:Organotechnetium Compounds / Q000493:pharmacokinetics; D010091:Oximes / Q000493:pharmacokinetics; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D017256:Technetium Tc 99m Sestamibi / Q000493:pharmacokinetics; D013794:Thallium Radioisotopes / Q000493:pharmacokinetics; D014665:Vasodilator Agents
D005663:Furans; D009943:Organophosphorus Compounds; D015609:Organotechnetium Compounds; D010091:Oximes; D019275:Radiopharmaceuticals; D013794:Thallium Radioisotopes; D014665:Vasodilator Agents; C078496:technetium Tc 99m Q12; C078700:technetium tc-99m tetrofosmin; D017256:Technetium Tc 99m Sestamibi; C060156:technetium Tc 99m teboroxime